1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Basic demographics of 180 subjects with HHT and brain VMs
CharacteristicSummarya (%)
Age at enrollment (mean) (yr)34.2 (SD, 21.1)
Women111/180 (61.7%)
Curaçao criteria
    Epistaxis168/180 (93.3%)
    Mucosal telangiectasias141/180 (78.3%)
    Pulmonary AVMs91/180 (50.6%)
    Liver VMs14/180 (7.8%)
    Gastrointestinal bleeding9/180 (5.0%)
    Affected first-degree relative135/180 (75%)
Genetic mutation
    ENG109/131 (83.2%)
    ACVRL121/131 (16.0%)
    SMAD41/131 (0.7%)
DSA116/180 (64.4%)
MRA114/180 (63.3%)
CTA5/180 (2.8%)
AVM113/180 (62.8%)
AVF16/180 (8.9%)
IAs9/180 (5%)
  • ↵a Summary is the number of observations with each value over the total available numbers (and the percentage) or the mean (SD) for continuous variables.